Acquired cutis laxa type II (Marshall syndrome) in a 3-month-old boy

Area of Science:

• Dermatology
• Pediatric Medicine
• Genetics

Background:

• Acquired cutis laxa type II (Marshall syndrome) is a rare elastolytic disorder.
• This condition typically manifests in infancy and childhood.
• Effective treatment options for acquired cutis laxa type II are limited.

Observation:

• A case study involving a 3-month-old boy is presented.
• The patient exhibited acquired cutis laxa type II.
• The condition was secondary to a neutrophilic dermatosis.

Findings:

• Acquired cutis laxa type II can arise secondary to neutrophilic dermatosis.
• The initial inflammatory phase of the dermatosis is critical.
• Prompt treatment of inflammation may prevent permanent skin damage.

Implications:

• Early diagnosis and treatment of neutrophilic dermatosis are vital in pediatric cases.
• Aggressive management of the inflammatory phase can mitigate the severity of acquired cutis laxa type II.
• This case highlights the importance of addressing underlying inflammatory conditions to prevent elastolysis.